Vanessa Taylor

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann, Vanessa Taylor, H. Zhao et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 511 citations

Life Sciences, Immunology, Pharmacology +17

The Myeloid-specific Sialic Acid-binding Receptor, CD33, Associates with the Protein-tyrosine Phosphatases, SHP-1 and SHP-2

Vanessa Taylor, Christopher D. Buckley, Michael E. Douglas et al. · Journal of Biological Chemistry · 1999 · 187 citations · Full text

Life Sciences, Immunology, Molecular Biology +11

5′ Phospholipid Phosphatase SHIP-2 Causes Protein Kinase B Inactivation and Cell Cycle Arrest in Glioblastoma Cells

Vanessa Taylor, Michelle Wong, Christian Brandts et al. · Molecular and Cellular Biology · 2000 · 185 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Differential association of cytoplasmic signalling molecules SHP‐1, SHP‐2, SHIP and phospholipase C‐γ1 with PECAM‐1/CD31

Nicholas J. Pumphrey, Vanessa Taylor, Sylvie Freeman et al. · FEBS Letters · 1999 · 102 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration

Ian N. Bird, Vanessa Taylor, Justin P. Newton et al. · Journal of Cell Science · 1999 · 82 citations

Life Sciences, Cell Biology, Molecular Biology +17